Vancomycin : Understanding Its Past and Preserving Its FutureLEVINE, Donald P.Southern medical journal (Birmingham). 2008, Vol 101, Num 3, pp 284-291, issn 0038-4348, 8 p.Article

Clinical experience with daptomycin : bacteraemia and endocarditisLEVINE, Donald P.Journal of antimicrobial chemotherapy (Print). 2008, Vol 62, issn 0305-7453, iii35-iii39, SUP3Article

Vancomyck : A historyLEVINE, Donald P.Clinical infectious diseases. 2006, Vol 42, issn 1058-4838, S5-S12, SUP1Article

Implementation of an Antimicrobial Stewardship Pathway with Daptomycin for Optimal Treatment of Methicillin-Resistant Staphylococcus aureus BacteremiaKULLAR, Ravina; DAVIS, Susan L; KAYE, Keith S et al.Pharmacotherapy. 2013, Vol 33, Num 1, pp 3-10, issn 0277-0008, 8 p.Article

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive SummaryLIU, Catherine; BAYER, Arnold; RYBAK, Michael J et al.Clinical infectious diseases. 2011, Vol 52, Num 3, pp 285-292, issn 1058-4838, 8 p.Article

Emergence of Coagulase-Negative Staphylococci as a Cause of Native Valve EndocarditisCHU, Vivian H; WOODS, Christopher W; MARCO, Francesc et al.Clinical infectious diseases. 2008, Vol 46, Num 2, pp 232-242, issn 1058-4838, 11 p.Article

Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial of a Polyclonal Anti-Staphylococcus aureus Capsular Polysaccharide Immune Globulin in Treatment of Staphylococcus aureus BacteremiaRUPP, Mark E; HOLLEY, H. Preston; LUTZ, Jon et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 12, pp 4249-4254, issn 0066-4804, 6 p.Article

Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureusLODISE, Thomas P; MCKINNON, Peggy S; LEVINE, Donald P et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 10, pp 3731-3733, issn 0066-4804, 3 p.Article

Staphylococcus aureus endocarditis : A consequence of medical progressFOWLER, Vance G; MIRO, Jose M; PAPPAS, Paul A et al.JAMA, the journal of the American Medical Association. 2005, Vol 293, Num 24, pp 3012-3021, issn 0098-7484, 10 p.Article

High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective StudyKULLAR, Ravina; DAVIS, Susan L; LEVINE, Donald P et al.Pharmacotherapy. 2011, Vol 31, Num 6, pp 527-536, issn 0277-0008, 10 p.Article

Therapeutic Monitoring of Vancomycin in Adults: Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsRYBAK, Michael J; LOMAESTRO, Ben M; ROTSCHAFER, John C et al.Pharmacotherapy. 2009, Vol 29, Num 11, pp 1275-1279, issn 0277-0008, 5 p.Article

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureusFOWLER, Vance G; BOUCHER, Helen W; CABELL, Christopher H et al.The New England journal of medicine. 2006, Vol 355, Num 7, pp 653-665, issn 0028-4793, 13 p.Article

Evaluation of Vancomycin Population Susceptibility Analysis Profile as a Predictor of Outcomes for Patients with Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureusCASAPAO, Anthony M; DAVIS, Susan L; MCROBERTS, John Paul et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4636-4641, issn 0066-4804, 6 p.Article

Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal InfectionsCASAPAO, Anthony M; KULLAR, Ravina; COSGROVE, Sara E et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 9, pp 4190-4196, issn 0066-4804, 7 p.Article

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases PharmacistsRYBAK, Michael J; LOMAESTRO, Ben M; ROTSCHAFER, John C et al.Clinical infectious diseases. 2009, Vol 49, Num 3, pp 325-327, issn 1058-4838, 3 p.Article

Once-daily aminoglycoside in the treatment of Enterococcus faecalis endocarditis : Case report and reviewTAM, Vincent H; MCKINNON, Peggy S; LEVINE, Donald P et al.Pharmacotherapy. 2000, Vol 20, Num 9, pp 1116-1119, issn 0277-0008Article

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested TargetsKULLAR, Ravina; DAVIS, Susan L; LEVINE, Donald P et al.Clinical infectious diseases. 2011, Vol 52, Num 8, pp 975-981, issn 1058-4838, 7 p.Article

Initial Low-Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is NephrotoxicCOSGROVE, Sara E; VIGLIANI, Gloria A; BOUCHER, Helen W et al.Clinical infectious diseases. 2009, Vol 48, Num 6, pp 713-721, issn 1058-4838, 9 p.Article

Daptomycin in the treatment of patients with infective endocarditis : Experience from a registryLEVINE, Donald P; LAMP, Kenneth C.The American journal of medicine. 2007, Vol 120, Num 10, issn 0002-9343, S28-S33, SUPAArticle

Clinafloxacin for the treatment of bacterial endocarditisLEVINE, Donald P; HOLLEY, H. Preston; EISEMAN, Irene et al.Clinical infectious diseases. 2004, Vol 38, Num 5, pp 620-631, issn 1058-4838, 12 p.Article